As no one else said they would watch the stream, I did (but only track 2 with Histogen and RepliCel). As expected, nothing too interesting from RepliCel which is not surprising as they are only starting the phase 3 trials right now. Histogen, on the other hand, was quite interesting - they apparently manage regrowth independent of the baldness state of an area. No matter how bald you are, they will give full regrowth within only a matter of weeks.
I'll just copy my notes:
Histogen
Need help with this statement, what does it mean?
Stanford
RepliCel
I'll just copy my notes:
Histogen
- HSC +126% terminal hairs count
- Growth and new follicle formation even months after treatment, so no repeated injections needed -> one injection session, full regrowth all over head
- physician trial: 100% effectiveness, all 10 clients had full regrowth
- HSC gives regrowth independent of age and how long target areas suffered from baldness
- HSC regulated as a biologic
- no mention of when phase 3 trials will start (which is a bad sign); they might not be completely happy with their Phase 2 results (i.e., havent found the perfect dose yet which does give perfect full regrowth in just one application or they need to find the minimum dose which achieves full regrowth because of potential risks of Wnt7, s. below notes on Stanford)
Need help with this statement, what does it mean?
- HSC falls under FDA biologics regulation instead of drug regulation
Stanford
- General stem cell multiplication via Wnt3A
- applies to hair too, no mention of concrete product, but a study for hair regenration is being carried out right now (early phase, probably pre-clinical)
- According to the presenter, Wnts (in general) activate not only stem/pluripotent cells but ALSO carcinogenic ones, thus Wnt should not be injected directly into patient but ONLY used for ex-vivo cultivation - this might apply to Histogen's treatment, unfortunately. Does Histogen only use Wnt7 for cultivation, or do they directly inject Wnt7 into the scalp?
- 30 months till they can COMMENCE clinial trials so they are ages away from any practical treatment if I understood this part correctly - stream got stuck here
RepliCel
- new Japanese regulation, about to be passed by their parliament within the next few months: only phase 1 and 2 needed for regenerative medicine and stem cell treatments for market clearance, nothing else. This would mean that RepliCel could potentially offer their hair treatment in Japan before phase 3 finishes. Question is whether the phase 1 & 2 trials for clearance need to be conducted in Japan for that or not, which is maybe part of the reason why Shiseido runs Phase 1/2 trials now in parallel.